1933 Industries CEO: Infrastructure Upgrades Expanding Cultivation Capacity by 500 Percent

1933 Industries Inc. (CSE:TGIF,OTCQX:TGIFF,FWB:IQF) CEO Chris Rebentisch recently joined the Stock Day podcast to discuss the company’s expansion plans, including a new 67,000-square-foot cannabis cultivation facility. Rebentisch also provided an overview of the company’s recent progress, including a partnership with skateboarding legend Tony Hawk.  

The company’s 67,000-square-foot, state-of-the-art indoor cultivation facility in Nevada is expected to increase 1933 Industries’ cultivation capacity by 500 percent. Rebentisch expects the first harvest from the facility to begin in December. As for the old facility, 1933 Industries intends to retrofit it to a 10,000-square-foot extraction facility, to ensure that the company can meet its current product quotas. According to Rebentisch, the company’s existing extraction facility is running for 16 hours per day to keep up with the current demand.

Despite the size advantages that the California market presents, Rebentisch believes that Arizona will be the next big market within the US. The population in Arizona alone is greater than the entire state of Nevada and the state “has already made US$750 million a year in medical cannabis sales, which is expected to triple when rec is green-lighted.” 1933 Industries is already servicing approximately half of the dispensaries in the state.

Rebentisch also addressed the direct-to-consumer trend that the industry has been seeing. He believes that the brands are what’s going to survive in the industry because people are going to buy that brand no matter where it is located. Brand consistency and quality are what is going to make consumers purchase and use the products. Rebentisch does believe that the retail aspect will move online and that those who are new to cannabis will continue to visit dispensaries for the first little bit to educate themselves and to ask questions before moving to the online platform as well.

To listen to the full interview, click here.

Click here to connect with 1933 Industries Inc. (CSE:TGIF,FWB:1QF,OTC:VPGDF) for an Investor Presentation.

Trulieve Partners with the Thurgood Marshall College Fund to Provide College Scholarships

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

Trulieve Opens Tamarac’s First Dispensary, Marking 75th Florida Location

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Announces Broadening of Share Liquidity With DTC Full-Service Eligibility

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. Launches Cannabis News Series to Broadcast on Bloomberg, Newsmax & Fox Business

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less